{
    "Trade/Device Name(s)": [
        "HemosIL Factor VIII Deficient Plasma"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K110237",
    "Predicate Device Reference 510(k) Number(s)": [
        "K034007"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJT"
    ],
    "Summary Letter Date": "July 8, 2011",
    "Summary Letter Received Date": "June 29, 2011",
    "Submission Date": "June 27, 2011",
    "Regulation Number(s)": [
        "21CFR864.7290"
    ],
    "Regulation Name(s)": [
        "Factor deficiency test"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Factor VIII"
    ],
    "Specimen Type(s)": [
        "Citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACL TOP Family analyzers",
        "ACL TOP base",
        "ACL TOP 700",
        "ACL TOP 500 CTS"
    ],
    "Method(s)/Technology(ies)": [
        "Activated partial thromboplastin time (APTT) assay",
        "Functional clotting assay"
    ],
    "Methodologies": [
        "Clotting time correction",
        "Calibration curve interpolation"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL Factor VIII Deficient Plasma used in quantitative determination of Factor VIII activity by APTT on ACL TOP analyzers.",
    "Indications for Use Summary": "Intended for in vitro diagnostic quantitative determination of Factor VIII activity in citrated plasma using APTT assay on the ACL TOP Family analyzers in patients suspected of congenital or acquired deficiency.",
    "fda_folder": "Hematology"
}